Latest Statin Stories
The Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3), which have been drawn up by 11 UK professional societies and charitable organizations, are based on the latest available scientific evidence.
Companies to Host Investor Conference Call on Alirocumab on March 31 at 9 AM EDT PARIS and TARRYTOWN, N.Y., March 27, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY)
National network of attorneys continues to offer no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statins. New
Five Phase 3 Studies With Evolocumab (AMG 145) to be Featured in Late-Breaking and Clinical Research Presentations - Data Form the Basis of Global Filing Plan THOUSAND OAKS, Calif., March 24,
At first, multiple sclerosis is recognized by sporadic neurological symptoms – a condition called relapsing-remitting MS. Within a decade or so, greater than 50 percent patients acquire secondary progressive MS, a continuous deterioration of symptoms and boost in disability.
The United States Judicial Panel (USJP) on Multidistrict Litigation (MDL) has recently issued a transfer order that will remit 56 Lipitor lawsuits and many more tag-along actions to the District
The firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, New
Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., March 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 TESLA (Trial Evaluating
The Firm is investigating Lipitor Lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to treatment with the cholesterol-lowering statin. New
- A trick or prank.